JRCT ID: jRCT2080220177
Registered date:22/11/2005
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Patients with ulcerative colitis in remission phase |
Date of first enrollment | 22/11/2005 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Z-206 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Non-incidence of bloody stool |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 16age old |
---|---|
Age maximum | <= 64age old |
Gender | Both |
Include criteria | Patients with ulcerative colitis in remission phase who are defined to show Ulcerative Colitis-Disease Activity Index (UC-DAI) score of not less than 2 and bloody stool score of 0. |
Exclude criteria |
Related Information
Primary Sponsor | ZERIA Pharmaceutical Co.,Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050180 |
Contact
Public contact | |
Name | |
Address | kaihatu@zeria.co.jp |
Telephone | |
Affiliation | ZERIA Pharmaceutical Co.,Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |